Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 1:05 pm Purchase |
2024-12-31 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
Havlickova 648 a.s. | 78,291 4.390% |
11,959 (+18.03%) |
Filing History |
| 2025-01-29 7:29 pm Purchase |
2025-01-23 | 13D | Cadrenal Therapeutics, Inc. Common Stock CVKD |
Pham Quang X | 421,042 23.600% |
421,042 (New Position) |
Filing History |
| 2025-01-15 4:23 pm Purchase |
2024-12-31 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
MURPHY JOHN RAYMOND | 53,205 2.960% |
53,205 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
Armistice Capital, LLC | 78,611 4.990% |
78,611 (New Position) |
Filing History |
| 2024-10-04 4:15 pm Purchase |
2024-09-20 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
Havlickova 648 a.s. | 66,332 6.200% |
66,332 (New Position) |
Filing History |
| 2024-02-14 3:34 pm Purchase |
2023-12-31 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
Armistice Capital, LLC | 93,292 9.990% |
93,292 (New Position) |
Filing History |
| 2024-02-13 5:18 pm Purchase |
2023-12-31 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
MURPHY JOHN RAYMOND | 47,653 5.490% |
8,000 (+20.18%) |
Filing History |
| 2024-02-12 9:42 pm Purchase |
2023-12-31 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
Pham Quang X | 421,667 48.570% |
421,667 (New Position) |
Filing History |
| 2023-03-27 06:09 am Purchase |
2023-03-16 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD |
MURPHY JOHN RAYMOND | 39,653 5.110% |
39,653 (New Position) |
Filing History |